{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:02:41Z","timestamp":1791406961023,"version":"4.3.3"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/nrendo.2015.30","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T03:49:46Z","timestamp":1425959386000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["The calcium-sensing receptor in bone\u2014mechanistic and therapeutic insights"],"prefix":"10.1038","volume":"11","author":[{"given":"David","family":"Goltzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey N.","family":"Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"key":"BFnrendo201530_CR1","doi-asserted-by":"publisher","first-page":"E724","DOI":"10.1152\/ajpendo.00557.2012","volume":"304","author":"SJ Quinn","year":"2013","unstructured":"Quinn, S. J.  et al. CaSR-mediated interactions between calcium and magnesium homeostasis in mice. Am. J. Physiol. Endocrinol. Metab. 304, E724\u2013E733 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201530_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1006\/bbrc.1995.2318","volume":"214","author":"K Aida","year":"1995","unstructured":"Aida, K., Koishi, S., Tawata, M. Y. & Onaya, T. Molecular cloning of a putative Ca2+-sensing receptor cDNA from human kidney. Biochem. Biophys. Res. Commun. 214, 524\u2013529 (1995).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo201530_CR3","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/hmg\/ddl145","volume":"15","author":"S Pidasheva","year":"2006","unstructured":"Pidasheva, S.  et al. Calcium-sensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of novel CASR mutations retained intracellularly. Hum. Mol. Genet. 15, 2200\u20132209 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo201530_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.beem.2013.03.003","volume":"27","author":"GE Breitwieser","year":"2013","unstructured":"Breitwieser, G. E. The calcium sensing receptor life cycle: trafficking, cell surface expression, and degradation. Best Pract. Res. Clin. Endocrinol. Metab. 27, 303\u2013313 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1476-5381.2011.01511.x","volume":"165","author":"DT Ward","year":"2012","unstructured":"Ward, D. T. & Riccardi, D. New concepts in calcium-sensing receptor pharmacology and signaling. Br. J. Pharmacol. 165, 35\u201348 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrendo201530_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.beem.2013.05.010","volume":"27","author":"AD Conigrave","year":"2013","unstructured":"Conigrave, A. D. & Ward, D. T. Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways. Best Pract. Res. Clin. Endocrinol. Metab. 27, 315\u2013331 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/366575a0","volume":"366","author":"EM Brown","year":"1993","unstructured":"Brown, E. M.  et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature 366, 575\u2013580 (1993).","journal-title":"Nature"},{"key":"BFnrendo201530_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1023\/A:1026570518919","volume":"1","author":"EM Brown","year":"2000","unstructured":"Brown, E. M. Calcium receptor and regulation of parathyroid hormone secretion. Rev. Endocr. Metab. Disord. 1, 307\u2013315 (2000).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"BFnrendo201530_CR9","doi-asserted-by":"publisher","first-page":"E915","DOI":"10.1152\/ajpendo.00315.2009","volume":"297","author":"L Kantham","year":"2009","unstructured":"Kantham, L.  et al. The calcium-sensing receptor defends against hypercalcemia independently of its regulation of parathyroid hormone secretion. Am. J. Physiol. Endocrinol. Metab. 297, E915\u2013E923 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201530_CR10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.tem.2010.04.002","volume":"21","author":"D Goltzman","year":"2010","unstructured":"Goltzman, D. Emerging roles for calcium-regulating hormones beyond osteolysis. Trends Endocrinol. Metab. 21, 512\u2013518 (2010).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrendo201530_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/ki.2014.215","volume":"86","author":"T Meir","year":"2014","unstructured":"Meir, T.  et al. Parathyroid hormone activates the orphan receptor Nurr1 to induce FGF23 transcription. Kidney Int. 86, 1106\u20131115 (2014).","journal-title":"Kidney Int."},{"key":"BFnrendo201530_CR12","doi-asserted-by":"publisher","first-page":"E310","DOI":"10.1152\/ajpendo.00460.2012","volume":"304","author":"SJ Quinn","year":"2013","unstructured":"Quinn, S. J.  et al. Interactions between calcium and phosphorus in the regulation of the production of fibroblast growth factor 23 in vivo. Am. J. Physiol. Endocrinol. Metab. 304, E310\u2013E320 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201530_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1172\/JCI17416","volume":"111","author":"CH Kos","year":"2003","unstructured":"Kos, C. H.  et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J. Clin. Invest. 111, 1021\u20131028 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201530_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamaoto.2014.2435","volume":"140","author":"S Noureldine","year":"2014","unstructured":"Noureldine, S., Genther, D. J., Lopez, M., Agarwal, N. & Tufano, R. P. Early predictors of hypocalcemia after total thyroidectomy: an analysis of 303 patients using a short-stay monitoring protocol. JAMA Otolaryngol. Head Neck Surg. 140, 1006\u20131013 (2014).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"BFnrendo201530_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1056\/NEJM197405092901901","volume":"290","author":"D Goltzman","year":"1974","unstructured":"Goltzman, D., Potts, J. T. Jr, Ridgeway, E. C. & Maloof, F. Calcitonin as a tumor marker\u2014use of the radioimmunoassay for calcitonin in the postoperative evaluation of patients with medullary thyroid carcinoma. N. Engl. J. Med. 290, 1035\u20131039 (1974).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201530_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(98)06434-4","volume":"353","author":"DE Cole","year":"1999","unstructured":"Cole, D. E.  et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 353, 112\u2013115 (1999).","journal-title":"Lancet"},{"key":"BFnrendo201530_CR17","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1093\/hmg\/ddq342","volume":"19","author":"CM O'Seaghdha","year":"2010","unstructured":"O'Seaghdha, C. M.  et al. Common variants in the calcium-sensing receptor are associated with total serum calcium levels. Hum. Mol. Genet. 19, 4296\u20134303 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrendo201530_CR18","doi-asserted-by":"publisher","first-page":"e1003796","DOI":"10.1371\/journal.pgen.1003796","volume":"9","author":"CM O'Seaghdha","year":"2013","unstructured":"O'Seaghdha, C. M.  et al. Meta-analysis of genome-wide association studies identifies six new loci for serum calcium concentrations. PLoS Genet. 9, e1003796 (2013).","journal-title":"PLoS Genet."},{"key":"BFnrendo201530_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.beem.2013.02.009","volume":"27","author":"GN Hendy","year":"2013","unstructured":"Hendy, G. N., Canaff, L. & Cole, D. E. The CASR gene: alternative splicing and transcriptional control, and calcium-sensing receptor (CaSR) protein: structure and ligand binding sites. Best Pract. Res. Clin. Endocrinol. Metab. 27, 285\u2013301 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR20","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1073\/pnas.95.7.4040","volume":"95","author":"EF Nemeth","year":"1998","unstructured":"Nemeth, E. F.  et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc. Natl Acad. Sci. USA 95, 4040\u20134045 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo201530_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1138\/20080318","volume":"5","author":"EF Nemeth","year":"2008","unstructured":"Nemeth, E. F. Anabolic therapy for osteoporosis: calcilytics. BoneKey 5, 196\u2013208 (2008).","journal-title":"BoneKey"},{"key":"BFnrendo201530_CR22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bone.2009.09.028","volume":"46","author":"S Kumar","year":"2010","unstructured":"Kumar, S.  et al. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone 46, 534\u2013542 (2010).","journal-title":"Bone"},{"key":"BFnrendo201530_CR23","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1172\/JCI9038","volume":"105","author":"M Gowen","year":"2000","unstructured":"Gowen, M.  et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J. Clin. Invest. 105, 1595\u20131604 (2000).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201530_CR24","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0021-9258(17)36032-5","volume":"261","author":"RR MacGregor","year":"1986","unstructured":"MacGregor, R. R., Jilka, R. L. & Hamilton, J. W. Formation and secretion of fragments of parathormone. Identification of cleavage sites. J. Biol. Chem. 261, 1929\u20131934 (1986).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201530_CR25","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0196-9781(00)00283-7","volume":"21","author":"BH Fasciotto","year":"2000","unstructured":"Fasciotto, B. H., Denny, J. C., Greeley, G. H. Jr & Cohn. D. V. Processing of chromogranin A in the parathyroid: generation of parastatin-related peptides. Peptides 21, 1389\u20131401 (2000).","journal-title":"Peptides"},{"key":"BFnrendo201530_CR26","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/S0021-9258(17)30025-X","volume":"254","author":"RR MacGregor","year":"1979","unstructured":"MacGregor, R. R., Hamilton, J. W., Shofstall, R. E. & Cohn, D. V. Isolation and characterization of porcine parathyroid cathepsin B. J. Biol. Chem. 254, 4423\u20134427 (1979).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201530_CR27","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1073\/pnas.0502249102","volume":"102","author":"Y Sabbagh","year":"2005","unstructured":"Sabbagh, Y., Carpenter, T. O. & Demay, M. B. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc. Natl Acad. Sci. USA 102, 9637\u20139642 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo201530_CR28","doi-asserted-by":"publisher","first-page":"16754","DOI":"10.1074\/jbc.M310271200","volume":"279","author":"DK Panda","year":"2004","unstructured":"Panda, D. K.  et al. Inactivation of the 25-hydroxyvitamin D 1\u03b1-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcum and vitamin D on skeletal and mineral homeostasis. J. Biol. Chem. 279, 16754\u201316766 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201530_CR29","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1083\/jcb.126.6.1611","volume":"126","author":"N Amizuka","year":"1994","unstructured":"Amizuka, N., Warshawsky, H., Henderson, J. E., Goltzman, D. & Karaplis, A. C. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell. Biol. 126, 1611\u20131623 (1994).","journal-title":"J. Cell. Biol."},{"key":"BFnrendo201530_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1677\/JOE-09-0183","volume":"204","author":"R Mamillapalli","year":"1994","unstructured":"Mamillapalli, R. & Wysolmerski, J. The calcium-sensing receptor couples to G\u03b1s and regulates PTHrP and ACTH secretion in pituitary cells. J. Endocrinol. 204, 287\u2013297 (1994).","journal-title":"J. Endocrinol."},{"key":"BFnrendo201530_CR31","doi-asserted-by":"publisher","first-page":"e1002294","DOI":"10.1371\/journal.pgen.1002294","volume":"7","author":"J Liu","year":"2011","unstructured":"Liu, J.  et al. The abnormal phenotypes of cartilage and bone in calcium-sensing receptor deficient mice are dependent on the actions of calcium, phosphorus, and PTH. PLoS Genet. 7, e1002294 (2011).","journal-title":"PLoS Genet."},{"key":"BFnrendo201530_CR32","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/endo.140.4.6639","volume":"140","author":"W Chang","year":"1999","unstructured":"Chang, W.  et al. Calcium sensing in cultured chondrogenic RCJ3.1C5.18 cells. Endocrinology 140, 1911\u20131919 (1999).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR33","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1210\/endo.143.4.8709","volume":"143","author":"W Chang","year":"2002","unstructured":"Chang, W., Tu, C., Pratt, S., Chen, T. H. & Shoback, D. Extracellular Ca2+-sensing receptors modulate matrix production and mineralization in chondrogenic RCJ3.1C5.18 cells. Endocrinology 143, 1467\u20131474 (2002).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR34","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1210\/en.2005-0437","volume":"146","author":"L Rodriguez","year":"2005","unstructured":"Rodriguez, L., Cheng, Z., Chen, T. H., Tu, C. & Chang, W. Extracellular calcium and parathyroid hormone-related peptide signaling modulate the pace of growth plate chondrocyte differentiation. Endocrinology 146, 4597\u20134608 (2005).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR35","doi-asserted-by":"publisher","first-page":"ra1","DOI":"10.1126\/scisignal.1159945","volume":"1","author":"W Chang","year":"2008","unstructured":"Chang, W., Tu, C., Chen, T. H., Bikle, D. & Shoback, D. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci. Signal. 1, ra1 (2008).","journal-title":"Sci. Signal."},{"key":"BFnrendo201530_CR36","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1681\/ASN.2009050531","volume":"21","author":"L Nguyen-Yamamoto","year":"2010","unstructured":"Nguyen-Yamamoto, L., Bolivar, I., Srugnell, S. A. & Goltzman, D. Comparison of vitamin D compounds and a calcimimetic in mineral homeostasis. J. Am. Soc. Nephrol. 21, 1713\u20131723 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrendo201530_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jbmr.58","volume":"25","author":"C Richard","year":"2010","unstructured":"Richard, C.  et al. The calcium-sensing receptor and 25-hydroxyvitamin D-1\u03b1-hydroxylase interact to modulate skeletal growth and bone turnover. J. Bone Miner. Res. 25, 1627\u20131636 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo201530_CR38","doi-asserted-by":"publisher","first-page":"5294","DOI":"10.1210\/en.2005-0256","volume":"146","author":"L Rodriguez","year":"2005","unstructured":"Rodriguez, L.  et al. Expression and functional assessment of an alternatively spliced extracellular Ca2+-sensing receptor in growth plate chondrocytes. Endocrinology 146, 5294\u20135303 (2005).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR39","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1172\/JCI200317054","volume":"111","author":"Q Tu","year":"2003","unstructured":"Tu, Q.  et al. Rescue of the skeletal phenotype in CaSR-deficient mice by transfer onto the Gcm2 null background. J. Clin. Invest. 111, 1029\u20131037 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201530_CR40","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1172\/JCI0214817","volume":"109","author":"D Miao","year":"2001","unstructured":"Miao, D., He, B., Karaplis, A. C. & Goltzman, D. Parathyroid hormone is essential for normal fetal bone formation. J. Clin. Invest. 109, 1173\u20131182 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201530_CR41","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1210\/en.2003-1097","volume":"145","author":"D Miao","year":"2004","unstructured":"Miao, D.  et al. Skeletal abnormalities in Pth-null mice are influenced by calcium. Endocrinology 145, 2046\u20132053 (2004).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR42","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1002\/jbmr.520","volume":"26","author":"MM Dvorak-Ewell","year":"2011","unstructured":"Dvorak-Ewell, M. M.  et al. Osteoblast extracellular Ca2+-sensing receptor regulates bone development, mineralization, and turnover. J. Bone Miner. Res. 26, 2935\u20132947 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo201530_CR43","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1210\/endo.140.12.7190","volume":"140","author":"W Chang","year":"1999","unstructured":"Chang, W.  et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 140, 5883\u20135893 (1999).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR44","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.1073\/pnas.0306141101","volume":"101","author":"MM Dvorak","year":"2004","unstructured":"Dvorak, M. M.  et al. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc. Natl Acad. Sci. USA 101, 5140\u20135145 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo201530_CR45","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1359\/jbmr.1998.13.10.1530","volume":"13","author":"T Yamaguchi","year":"1998","unstructured":"Yamaguchi, T.  et al. Mouse osteoblastic cell line (MC3T3-E1) expresses extracellular calcium (Ca2+)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J. Bone Miner. Res. 13, 1530\u20131538 (1998).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo201530_CR46","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1210\/en.2003-1127","volume":"145","author":"N Chattopadhyay","year":"2004","unstructured":"Chattopadhyay, N.  et al. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 145, 3451\u20133562 (2004).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR47","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1006\/bbrc.2000.3955","volume":"279","author":"T Yamaguchi","year":"2000","unstructured":"Yamaguchi, T., Chattopadhyay, N., Kifor, O., Sanders, J. L. & Brown, E. M. Activation of p42\/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line. Biochem. Biophys. Res. Commun. 279, 363\u2013368 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo201530_CR48","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.pharmthera.2012.07.009","volume":"136","author":"Z Saidak","year":"2012","unstructured":"Saidak, Z. & Marie, P. J. Strontium signalling: molecular mechanisms and therapeutic implications in osteoporosis. Pharmacol. Ther. 136, 216\u2013226 (2012).","journal-title":"Pharmacol. Ther."},{"key":"BFnrendo201530_CR49","doi-asserted-by":"publisher","first-page":"E608","DOI":"10.1152\/ajpendo.00229.2004","volume":"288","author":"M Yamauchi","year":"2005","unstructured":"Yamauchi, M., Yamaguchi, T., Kaji, H., Sugimoto, T. & Chihara, K. Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells. Am. J. Physiol. Endocrinol. Metab. 288, E608\u2013E616 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201530_CR50","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1210\/en.2003-1127","volume":"145","author":"N Chattopadhyay","year":"2004","unstructured":"Chattopadhyay, N.  et al. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 145, 3451\u20133412 (2004).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR51","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1055\/s-0030-1255091","volume":"42","author":"S Takaoka","year":"2010","unstructured":"Takaoka, S., Yamaguchi, T., Yano, S., Yamauchi, M. & Sugimoto, T. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization. Horm. Metab. Res. 42, 627\u2013631 (2010).","journal-title":"Horm. Metab. Res."},{"key":"BFnrendo201530_CR52","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/j.1476-5381.2009.00305.x","volume":"157","author":"TC Brennan","year":"2009","unstructured":"Brennan, T. C.  et al. Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br. J. Pharmacol. 157, 1291\u20131300 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrendo201530_CR53","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00198-008-0728-6","volume":"20","author":"GJ Atkins","year":"2009","unstructured":"Atkins, G. J., Welldon, K. J., Halbout, P. & Findlay, D. M. Strontium ranelate treatment of human primary osteoblasts promotes and osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporosis Int. 20, 653\u2013664 (2009).","journal-title":"Osteoporosis Int."},{"key":"BFnrendo201530_CR54","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1111\/j.1582-4934.2008.00673.x","volume":"13","author":"O Fromigu\u00e9","year":"2009","unstructured":"Fromigu\u00e9, O.  et al. Calcium-sensing receptor-dependent and receptor-independent activation of osteoblasts replication and survival by strontium ranelate. J. Cell. Mol. Med. 13, 2189\u20132199 (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrendo201530_CR55","first-page":"15","volume":"3","author":"M Pi","year":"2010","unstructured":"Pi, M., Chen, J., Zhu, W. & Quarles, L. D. Dominant negative effect of the extracellular domain of CASR. J. Receptor Ligand Channel Res. 3, 15\u201323 (2010).","journal-title":"J. Receptor Ligand Channel Res."},{"key":"BFnrendo201530_CR56","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1210\/en.2008-0654","volume":"150","author":"G Cao","year":"2009","unstructured":"Cao, G.  et al. Parathyroid hormone contributes to regulating milk calcium content and modulates neonatal bone formation cooperatively with calcium. Endocrinology 150, 561\u2013569 (2009).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR57","doi-asserted-by":"publisher","first-page":"40201","DOI":"10.1074\/jbc.M505186200","volume":"280","author":"M Pi","year":"2005","unstructured":"Pi, M.  et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J. Biol. Chem. 280, 40201\u201340209 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201530_CR58","doi-asserted-by":"publisher","first-page":"e3858","DOI":"10.1371\/journal.pone.0003858","volume":"3","author":"M Pi","year":"2008","unstructured":"Pi, M.  et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS ONE 3, e3858 (2008).","journal-title":"PLoS ONE"},{"key":"BFnrendo201530_CR59","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1677\/JME-08-0149","volume":"42","author":"P Wellendorph","year":"2009","unstructured":"Wellendorph, P.  et al. No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions. J. Mol. Endocrinol. 42, 215\u2013223 (2009).","journal-title":"J. Mol. Endocrinol."},{"key":"BFnrendo201530_CR60","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/jbmr.300","volume":"26","author":"L Shu","year":"2011","unstructured":"Shu, L.  et al. The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates. J. Bone Miner. Res. 26, 1057\u20131071 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo201530_CR61","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.1152\/ajpendo.00599.2011","volume":"302","author":"Y Xue","year":"2012","unstructured":"Xue, Y.  et al. The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice. Am. J. Physiol. Endocrinol. Metab. 302, E841\u2013E851 (2012).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201530_CR62","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1359\/jbmr.1997.12.12.1959","volume":"12","author":"MG House","year":"1997","unstructured":"House, M. G.  et al. Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J. Bone Miner. Res. 12, 1959\u20131970 (1997).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo201530_CR63","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/bbrc.1999.0932","volume":"261","author":"M Kanatani","year":"1999","unstructured":"Kanatani, M., Sugimoto, T., Kanazawa, M., Yano, S. & Chihara, K. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. Biochem. Biophys. Res. Commun. 261, 144\u2013148 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo201530_CR64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/bbrc.1998.8448","volume":"245","author":"T Kameda","year":"1998","unstructured":"Kameda, T.  et al. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem. Biophys. Res. Commun. 245, 419\u2013427 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrendo201530_CR65","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/BF01114813","volume":"9","author":"HK Datta","year":"1989","unstructured":"Datta, H. K., MacIntyre, I. & Zaidi, M. The effect of extracellular calcium elevation on morphology and function of isolated rat osteoclasts. Biosci. Rep. 9, 747\u2013751 (1989).","journal-title":"Biosci. Rep."},{"key":"BFnrendo201530_CR66","doi-asserted-by":"publisher","first-page":"14342","DOI":"10.1016\/S0021-9258(18)71683-9","volume":"264","author":"A Malgaroli","year":"1989","unstructured":"Malgaroli, A., Meldolesi, J., Zallone, A. Z. & Teti, A. Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J. Biol. Chem. 264, 14342\u201314347 (1989).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201530_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1113\/jphysiol.1990.sp018242","volume":"429","author":"BS Moonga","year":"1990","unstructured":"Moonga, B. S., Moss, D. W., Patchell, A. & Zaidi, M. Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption. J. Physiol. 429, 29\u201345 (1990).","journal-title":"J. Physiol."},{"key":"BFnrendo201530_CR68","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/jcp.1041490310","volume":"149","author":"M Zaidi","year":"1991","unstructured":"Zaidi, M.  et al. Divalent cations mimic the inhibitory effect of extracellular ionized calcium on bone resorption by isolated rat osteoclasts: further evidence for a \u201ccalcium receptor\u201d. J. Cell. Physiol. 149, 422\u2013427 (1991).","journal-title":"J. Cell. Physiol."},{"key":"BFnrendo201530_CR69","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1096\/fj.06-6304fje","volume":"20","author":"R Mentaverri","year":"2006","unstructured":"Mentaverri, R.  et al. The calcium-sensing receptor is directly involved in both osteoclast differentiation and apoptosis. FASEB J. 20, 2562\u20132564 (2006).","journal-title":"FASEB J."},{"key":"BFnrendo201530_CR70","first-page":"89","volume":"13","author":"V Shaloub","year":"2003","unstructured":"Shaloub, V.  et al. In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells. Crit. Rev. Eukaryot. Gene Expr. 13, 89\u2013106 (2003).","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"BFnrendo201530_CR71","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1210\/en.2007-0147","volume":"148","author":"MM Dvorak","year":"2007","unstructured":"Dvorak, M. M.  et al. Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone. Endocrinology 148, 3156\u20133163 (2007).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR72","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1172\/JCI45890","volume":"122","author":"L Lieben","year":"2012","unstructured":"Lieben, L.  et al. Normocalcemia is maintained in mice under conditions of malabsorption by vitamin D-induced inhibition of bone mineralization. J. Clin. Invest. 122, 1803\u20131815 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201530_CR73","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1152\/physrev.1991.71.2.371","volume":"71","author":"EM Brown","year":"1991","unstructured":"Brown, E. M. Extracellular Ca2+ signaling, regulation of parathyroid cell function, and role of Ca2+ and other ions as extracellular (first) messengers. Physiol. Rev. 71, 371\u2013411 (1991).","journal-title":"Physiol. Rev."},{"key":"BFnrendo201530_CR74","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0014-4827(88)90191-7","volume":"175","author":"IA Silver","year":"1988","unstructured":"Silver, I. A., Murrills, R. J. & Etherington, D. J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell Res. 175, 266\u2013276 (1988).","journal-title":"Exp. Cell Res."},{"key":"BFnrendo201530_CR75","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1210\/endo.142.9.8364","volume":"142","author":"SC Garner","year":"2001","unstructured":"Garner, S. C., Pi, M., Tu, Q. & Quarles, L. D. Rickets in calcium-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology 142, 3996\u20134005 (2001).","journal-title":"Endocrinology"},{"key":"BFnrendo201530_CR76","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/ng1295-389","volume":"11","author":"C Ho","year":"1995","unstructured":"Ho, C.  et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat. Genet. 11, 389\u2013394 (1995).","journal-title":"Nat. Genet."},{"key":"BFnrendo201530_CR77","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1242\/dev.045898","volume":"137","author":"W Sun","year":"2010","unstructured":"Sun, W.  et al. Alterations in phosphorus, calcium and PTHrP contribute to defects in dental and dental alveolar bone formation in calcium-sensing receptor-deficient mice. Development 137, 985\u2013992 (2010).","journal-title":"Development"},{"key":"BFnrendo201530_CR78","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000091378","volume":"181","author":"R Gopalakrishnan","year":"2005","unstructured":"Gopalakrishnan, R., Suttamanatwong, S., Carlson, S., Carlson, A. E. & Franceschi, R. T. Role of matrix Gla protein in parathyroid hormone inhibition of osteoblast mineralization. Cells Tissues Organs 181, 166\u2013175 (2005).","journal-title":"Cells Tissues Organs"},{"key":"BFnrendo201530_CR79","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI10523","volume":"107","author":"Y Imanishi","year":"2001","unstructured":"Imanishi, Y.  et al. Primary hyperparathyroidism caused by parathyroid-targeted expression of cyclin D1 in transgenic mice. J. Clin. Invest. 107, 1093\u20131102 (2001).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201530_CR80","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1210\/jcem-70-4-930","volume":"70","author":"M Parisien","year":"1990","unstructured":"Parisien, M.  et al. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J. Clin. Endocrinol. Metab. 70, 930\u2013938 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR81","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","volume":"53","author":"M Wada","year":"1998","unstructured":"Wada, M.  et al. NPS R-568 halts or reverses osteotis fibrosa in uremic rats. Kidney Int. 53, 448\u2013453 (1998).","journal-title":"Kidney Int."},{"key":"BFnrendo201530_CR82","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejphar.2009.05.013","volume":"616","author":"C Henley","year":"2009","unstructured":"Henley, C.  et al. The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats. Eur. J. Pharmacol. 616, 306\u2013313 (2009).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrendo201530_CR83","doi-asserted-by":"publisher","first-page":"F1315","DOI":"10.1152\/ajprenal.00552.2009","volume":"298","author":"JL Finch","year":"2010","unstructured":"Finch, J. L.  et al. Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am. J. Physiol. Renal Physiol. 298, F1315\u2013F1322 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrendo201530_CR84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1877-1173(09)89003-0","volume":"89","author":"GN Hendy","year":"2009","unstructured":"Hendy, G. N., Guarnieri, V. & Canaff, L. Calcium-sensing receptor and associated diseases. Prog. Mol. Biol. Transl. Sci. 89, 31\u201395 (2009).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"BFnrendo201530_CR85","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.beem.2013.04.007","volume":"27","author":"FM Hannan","year":"2013","unstructured":"Hannan, F. M. & Thakker, R. V. Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Pract. Res. Clin. Endocrinol. Metab. 27, 359\u2013371 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR86","first-page":"120","volume":"206","author":"FH Menko","year":"1983","unstructured":"Menko, F. H.  et al. Familial benign hypercalcemia. Study of a large family. Quart. J. Med. 206, 120\u2013140 (1983).","journal-title":"Quart. J. Med."},{"key":"BFnrendo201530_CR87","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2265.1987.tb00830.x","volume":"26","author":"JH Kristiansen","year":"1987","unstructured":"Kristiansen, J. H., R\u00f8dbro, P., Christiansen, C., Johansen, J. & Jensen, J. T. Familial hypocalciuric hypercalcemia. III: Bone mineral metabolism. Clin. Endocrinol. (Oxf.) 26, 713\u2013716 (1987).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201530_CR88","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00223-014-9877-0","volume":"95","author":"NF Jakobsen","year":"2014","unstructured":"Jakobsen, N. F.  et al. Increased trabecular volumetric bone mass density in familial hypocalciuric hypercalcemia (FHH) type 1: a cross-sectional study. Calcif. Tissue Int. 95, 141\u2013152 (2014).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrendo201530_CR89","first-page":"397","volume":"158","author":"S Abugassa","year":"1992","unstructured":"Abugassa, S., Nordenstrom, J. & J\u00e4hult, J. Bone mineral density in patients with familial hypocalciuric hypercalcemia (FHH). Eur. J. Surg. 158, 397\u2013402 (1992).","journal-title":"Eur. J. Surg."},{"key":"BFnrendo201530_CR90","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1365-2265.2009.03557.x","volume":"71","author":"SE Christensen","year":"2009","unstructured":"Christensen, S. E.  et al. Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism. Clin. Endocrinol. 71, 798\u2013807 (2009).","journal-title":"Clin. Endocrinol."},{"key":"BFnrendo201530_CR91","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0025-6196(12)65614-6","volume":"59","author":"WM Law Jr.","year":"1984","unstructured":"Law, W. M. Jr., Wahner, H. W. & Heath, H. 3rd. Bone mineral density and skeletal fractures in familial benign hypercalcemia (hypocalciuric). Mayo Clin. Proc. 59, 811\u2013815 (1984).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrendo201530_CR92","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00223-011-9517-x","volume":"89","author":"T Isaksen","year":"2011","unstructured":"Isaksen, T.  et al. Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. Calcif. Tissue Int. 89, 285\u2013294 (2011).","journal-title":"Calcif. Tissue Int."},{"key":"BFnrendo201530_CR93","doi-asserted-by":"publisher","first-page":"E707","DOI":"10.1210\/jc.2010-1306","volume":"96","author":"CM Reh","year":"2011","unstructured":"Reh, C. M., Hendy, G. N., Cole, D. E. & Jeandron, D. D. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefits from cinacalcet. J. Clin. Endocrinol. Metab. 96, E707\u2013E712 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR94","doi-asserted-by":"publisher","first-page":"e812","DOI":"10.1542\/peds.2011-0128","volume":"129","author":"A Wilhelm-Bals","year":"2012","unstructured":"Wilhelm-Bals, A., Parvex, P., Magdelaine, C. & Girardin, E. Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism. Pediatrics 129, e812\u2013e816 (2012).","journal-title":"Pediatrics"},{"key":"BFnrendo201530_CR95","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00467-010-1547-5","volume":"25","author":"US Alon","year":"2010","unstructured":"Alon, U. S. & VandeVoorde, R. G. Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia. Pediatr. Nephrol. 25, 1747\u20131750 (2010).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrendo201530_CR96","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1359\/jbmr.081233","volume":"24","author":"TA Theman","year":"2009","unstructured":"Theman, T. A.  et al. PTH1\u201334 replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. J. Bone Miner. Res. 24, 964\u2013973 (2009).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo201530_CR97","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/jc.2004-0842","volume":"90","author":"M Peacock","year":"2005","unstructured":"Peacock, M.  et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 90, 135\u2013141 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR98","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1210\/jc.2009-1472","volume":"94","author":"M Peacock","year":"2009","unstructured":"Peacock, M.  et al. Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study. J. Clin. Endocrinol. Metab. 94, 4860\u20134867 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR99","doi-asserted-by":"publisher","unstructured":"Marotta, V.  et al. Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. Endocrine http:\/\/dx.doi.org\/10.1007\/s12020-014-0381\u20130.","DOI":"10.1007\/s12020-014-0381-0"},{"key":"BFnrendo201530_CR100","first-page":"729","volume":"80","author":"SJ Silverberg","year":"1995","unstructured":"Silverberg, S. J.  et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 80, 729\u2013734 (1995).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR101","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S8756-3282(99)00207-0","volume":"25","author":"P Christiansen","year":"1999","unstructured":"Christiansen, P.  et al. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone 25, 589\u2013595 (1999).","journal-title":"Bone"},{"key":"BFnrendo201530_CR102","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S8756-3282(99)00150-7","volume":"25","author":"P Christiansen","year":"1999","unstructured":"Christiansen, P.  et al. Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone 25, 237\u2013244 (1999).","journal-title":"Bone"},{"key":"BFnrendo201530_CR103","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2265.2007.03109.x","volume":"68","author":"B Moosgaard","year":"2008","unstructured":"Moosgaard, B.  et al. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 68, 707\u2013715, (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo201530_CR104","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00004424-198211000-00013","volume":"17","author":"DC Leppla","year":"1982","unstructured":"Leppla, D. C., Snyder, W. & Pak, C. Y. Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism. Invest. Radiol. 17, 604\u2013606 (1982).","journal-title":"Invest. Radiol."},{"key":"BFnrendo201530_CR105","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","volume":"92","author":"E Ambrogini","year":"2007","unstructured":"Ambrogini, E.  et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J. Clin. Endocrinol. Metab. 92, 3114\u20133121 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR106","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/jc.2006-1836","volume":"92","author":"J Bollerslev","year":"2007","unstructured":"Bollerslev, J.  et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 92, 1687\u20131692 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR107","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1210\/jc.2013-1518","volume":"98","author":"E Koumakis","year":"2013","unstructured":"Koumakis, E.  et al. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 98, 3213\u20133220 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR108","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-14-0343","volume":"171","author":"C Eller-Vainicher","year":"2014","unstructured":"Eller-Vainicher, C.  et al. Factors associated with vertebral fracture risk in patients with primary hyperparathyroidism. Eur. J. Endocrinol. 171, 399\u2013406 (2014).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo201530_CR109","doi-asserted-by":"publisher","unstructured":"Ballinger, A. E., Palmer, S. C., Nistor, I., Craig, J. C. & Strippoli, G. F. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database of Systematic Reviews, Issue 12. Art. No.: CD006254. http:\/\/dx.doi.org\/10.1002\/14651858.CD006254.pub2.","DOI":"10.1002\/14651858.CD006254.pub2"},{"key":"BFnrendo201530_CR110","doi-asserted-by":"publisher","first-page":"e1001436","DOI":"10.1371\/journal.pmed.1001436","volume":"10","author":"SC Palmer","year":"2013","unstructured":"Palmer, S. C.  et al. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med. 10, e1001436 (2013).","journal-title":"PLoS Med."},{"key":"BFnrendo201530_CR111","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5414\/CNP68063","volume":"68","author":"G Jean","year":"2007","unstructured":"Jean, G. Chazot, C. & Charra, B. 12 months cinacalcet therapy in hemodialysis patients with secondary hyperparathyroidism: effect on bone markers. Clin. Nephrol. 68, 63\u201364 (2007).","journal-title":"Clin. Nephrol."},{"key":"BFnrendo201530_CR112","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/ndt\/gfh829","volume":"20","author":"YH Lien","year":"2005","unstructured":"Lien, Y. H., Silva, A. L. & Whittman, D. Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism. Nephrol. Dial. Transplant. 20, 1232\u20131237 (2005).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrendo201530_CR113","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5414\/CNP69269","volume":"69","author":"HH Malluche","year":"2008","unstructured":"Malluche, H. H.  et al. An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin. Nephrol. 69, 269\u2013278 (2008).","journal-title":"Clin. Nephrol."},{"key":"BFnrendo201530_CR114","doi-asserted-by":"publisher","unstructured":"Behets, G. J.  et al. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int. http:\/\/dx.doi.org\/10.1038\/ki.2014.349.","DOI":"10.1038\/ki.2014.349"},{"key":"BFnrendo201530_CR115","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1111\/j.1744-9987.2008.00630.x","volume":"1","author":"A Yajima","year":"2008","unstructured":"Yajima, A., Akizawa, T., Tsukamoto, Y., Kurihara, S. & Ito, A. Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism. Ther. Apher. Dial. 1, S38\u2013S43 (2008).","journal-title":"Ther. Apher. Dial."},{"key":"BFnrendo201530_CR116","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/jbmr.554","volume":"27","author":"LA Fitzpatrick","year":"2012","unstructured":"Fitzpatrick, L. A.  et al. Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women. J. Bone Miner. Res. 27, 255\u2013262 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrendo201530_CR117","doi-asserted-by":"publisher","first-page":"E2207","DOI":"10.1210\/jc.2013-4009","volume":"99","author":"J Halse","year":"2014","unstructured":"Halse, J.  et al. A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis. J. Clin. Endocrinol. Metab. 99, E2207\u2013E2215 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201530_CR118","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.beem.2013.02.008","volume":"27","author":"EF Nemeth","year":"2013","unstructured":"Nemeth, E. F. & Shoback, D. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders. Best Pract. Res. Clin. Endocrinol. Metab. 27, 373\u2013384 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.30","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T01:11:16Z","timestamp":1650330676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2015.30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFnrendo201530"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2015.30","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]},"assertion":[{"value":"10 March 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}